Shares of biotechnology company Pluristem Therapeutics Inc. bounced back Friday after the company responded to a report that a patient treated with its PLX stem cell therapy had died.
http://www.drugs.com/news/pluristem-shares-bounce-back-after-thursday-plunge-41476.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-HeadlineNews+%28Drugs.com+-+Headline+News%29
http://www.drugs.com/news/pluristem-shares-bounce-back-after-thursday-plunge-41476.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-HeadlineNews+%28Drugs.com+-+Headline+News%29
No comments:
Post a Comment